PATENT CLAIM ANALYSIS

Application Number: 16163029
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "443000"]

Abstract:
The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.

Claim (Index 10):
The composition of  claim 9 , wherein the antioxidant is selected from the group consisting of BHT, BHA, citric acid, propyl gallate, sodium sulfate, sodium metabisulfite, ascorbic acid, tocopherol, tocopherol ester derivatives, 2-mercaptobenzimidazole, and combinations thereof.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 97.0
- Lexical Diversity: 1.57447
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14196082', '15069875', '12537571', '14989669', '14390322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.780258612653457
- 35 USC 102 Novelty (BERT): 0.5262590516945744
- Combined Prediction Score: 0.7548586565575687
- Mean Citation Score: 303.289772
- Max Citation Score: 348.54297
- Similarity Product: 254.32373389122608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test